Literature DB >> 28973278

The Dangers of Polypharmacy in Elderly Patients.

Jacques Turgeon1,2, Veronique Michaud1,2, Lauren Steffen2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28973278     DOI： 10.1001/jamainternmed.2017.4790

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  Continue or not to continue? Attitudes towards deprescribing among community-dwelling older adults in China.

Authors:  Jie Tan; MinHong Wang; XiaoRui Pei; Quan Sun; ChongJun Lu; Ying Wang; Li Zhang; Chenkai Wu
Journal:  BMC Geriatr       Date:  2022-06-08       Impact factor: 4.070

2.  Evaluation of multiple drug use in patients with type 2 diabetes mellitus.

Authors:  Habibe İnci
Journal:  Diabetol Int       Date:  2021-02-07

3.  Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.

Authors:  M Àngels Pons-Mesquida; Míriam Oms-Arias; Eduard Diogène-Fadini; Albert Figueras
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-15       Impact factor: 2.796

4.  Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models.

Authors:  Sweilem B Al Rihani; Malavika Deodhar; Lucy I Darakjian; Pamela Dow; Matt K Smith; Ravil Bikmetov; Jacques Turgeon; Veronique Michaud
Journal:  Drugs Aging       Date:  2021-11-09       Impact factor: 3.923

5.  Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit.

Authors:  M Àngels Pons-Mesquida; Míriam Oms-Arias; Albert Figueras; Eduard Diogène-Fadini
Journal:  BMC Med Inform Decis Mak       Date:  2022-03-19       Impact factor: 2.796

6.  Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study.

Authors:  Tae Ik Chang; Haeyong Park; Dong Wook Kim; Eun Kyung Jeon; Connie M Rhee; Kamyar Kalantar-Zadeh; Ea Wha Kang; Shin-Wook Kang; Seung Hyeok Han
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.